Director/PDMR Shareholding

RNS Number : 7180T

GlaxoSmithKline PLC

01 October 2010

 



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.

On 30 September 2010, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £12.57 per Ordinary share and $39.77 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2010 to 30 September 2010:

Non Executive Director	Ordinary Shares	American Depository Shares (ADSs)
Sir Christopher Gent	2,684.96
Prof. Sir Roy Anderson	522.08
Dr Stephanie Burns		384.85
Mr Lawrence Culp		769.71
Sir Crispin Davis	1,889.42
Sir Deryck Maughan		1,077.59
Mr James Murdoch	1,491.65
Dr Daniel Podolsky		1,039.10
Mr Tom de Swaan	770.68
Sir Robert Wilson	522.08

The Company and the Non-Executive Directors were informed of these allocations on 1 October 2010.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

S M Bicknell

Company Secretary

1 October 2010

 

END

 

 

RDSFFLFBBBFZFBK